131I-meta-iodobenzylguanidine in the treatment of the high risk neuroblastoma patients - Experiences from the Department of Pediatric Oncology in Faculty Hospital Motol in Prague;131I metajodobenzylguanidin v kombinaci s hyperbarickou oxygenoterapií v léčbě prognosticky vysoce nepříznivý ch forem neuroblastomu

Casopis Lekaru Ceskych

Volumn 140, Issue 1, 2001, Pages 13-17

  Stankova J ^a   Kavan, P ^a   Krizova H ^a   Hermanska E ^a   Dosel P ^a   Sazel M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

131I MIBG; Hyperbaric oxygen therapy; Neuroblastoma; Targeted radiotherapy; Therapy

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; (3 IODOBENZYL)GUANIDINE; ANTINEOPLASTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; COST; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERBARIC OXYGEN; MALE; NEPHROTOXICITY; NEUROBLASTOMA; RADIATION DOSE; RETROSPECTIVE STUDY; ADOLESCENT; CHILD; MULTIMODALITY CANCER THERAPY; PRESCHOOL CHILD;

3-IODOBENZYLGUANIDINE; ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERBARIC OXYGENATION; MALE; NEUROBLASTOMA; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES;

EID: 0035910715     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. 131I MIBG in malignant pheochromocytoma and neuroblastoma: Case Report
2. Meta-iodobenzylguanidin (MIBG): Jeho diagnostický a lé̌ebný význam u neuroblastomu
3. Radionuclide therapy of neural crest tumors
4. Meta-iodobenzylguanidin in children
5. Clinical experience with radiation enhancement by hyperbaric oxygen in children with recurent neuroblastoma stage IV
6. Pokroky v diagnostice a léčbě neuroblastomu
7. Metaiodobenzylguanidine (MIBG) in treatment of 47 patients with neuroblastoma: Results of the German Neuroblastoma Trial
8. 131I-metaiodobenzylguanidine therapy for patients with refractory neuroblastoma
9. The effect of cisplatin pretreatment on the accumulation of MIBG by neuroblastoma cells in vitro
10. 131I-MIBG as a first-line treatment in high-risk neuroblastoma patiens
11. First line targeted radiotherapy, A new concept in the treatment of advanced stage neuroblastoma
12. 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma
13. 131I-metaiodobenzylguanidine in chemoresistant neuroblastoma: A United Kingdom Children's Cancer Study Group investigation
14. 131-I-Metaiodobenzylguanidine treatment in patients with refractory advanced neuroblastoma
15. 131I-metaiodobenzylguanidine therapy for patients with refractory neuroblastoma
16. Radiolabeled MIBG in the treatment of neuroblastoma
17. 131I-metaiodobenzylguanidine at diagnosis
18. Increase of metaiodobenzylguanidine uptake and intracellular half-life during differentiation of human neuroblastoma cells
19. Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG)
20. 131I-metaiodobenzylguanidine and cisplatin combination in advanced neuroblastoma
21. 131I-metaiodobenzylguanidine and high-dose chemotherapy with bone marrow rescue in advanced neuroblastoma
22. 131I-MIBG) therapy for residual neuroblastoma: A mono-institutional experience with 43 patients
23. 131I-metaiodobenzylguanidine
24. 131I MIBG treatment for children with neuroblastoma